Role of Extended-release Niacin on Immune Activation in HIV-infected Patients Treated With Antiretroviral Therapy: a Proof-of-concept Study
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 29 Mar 2017
At a glance
- Drugs Niacin (Primary)
- Indications HIV infections
- Focus Pharmacodynamics; Proof of concept
- 07 Jun 2017 Biomarkers information updated
- 21 Mar 2017 Planned End Date changed from 1 Nov 2016 to 1 Jun 2017.
- 21 Mar 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Jun 2017.